171 related articles for article (PubMed ID: 11181427)
1. Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions.
Smith-White MA; Hardy TA; Brock JA; Potter EK
Br J Pharmacol; 2001 Feb; 132(4):861-8. PubMed ID: 11181427
[TBL] [Abstract][Full Text] [Related]
2. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.
Serone AP; Wright CE; Angus JA
Br J Pharmacol; 1999 May; 127(1):99-108. PubMed ID: 10369461
[TBL] [Abstract][Full Text] [Related]
4. Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo.
Malmström RE
Br J Pharmacol; 2001 Aug; 133(7):1073-80. PubMed ID: 11487518
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway.
Herring N; Lokale MN; Danson EJ; Heaton DA; Paterson DJ
J Mol Cell Cardiol; 2008 Mar; 44(3):477-85. PubMed ID: 17996892
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
Tu B; Jiao Y; Herzog H; Nadler JV
Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
[TBL] [Abstract][Full Text] [Related]
7. Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse.
Smith-White MA; Iismaa TP; Potter EK
Br J Pharmacol; 2003 Sep; 140(1):170-8. PubMed ID: 12967946
[TBL] [Abstract][Full Text] [Related]
8. NPY Y2 receptor agonist, N-acetyl [Leu28,Leu31]NPY24-36, reduces renal vasoconstrictor activity in anaesthetised dogs.
Mahns DA; Kelly C; McCloskey DI; Potter EK
J Auton Nerv Syst; 1999 Oct; 78(1):10-7. PubMed ID: 10589818
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
Bacchi F; Mathé AA; Jiménez P; Stasi L; Arban R; Gerrard P; Caberlotto L
Peptides; 2006 Dec; 27(12):3202-7. PubMed ID: 16959374
[TBL] [Abstract][Full Text] [Related]
10. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.
El Bahh B; Cao JQ; Beck-Sickinger AG; Colmers WF
Br J Pharmacol; 2002 Jun; 136(4):502-9. PubMed ID: 12055128
[TBL] [Abstract][Full Text] [Related]
11. Modulation of sympathetic neurotransmission by neuropeptide Y Y2 receptors in rats and guinea pigs.
Potter EK; Tripovic D
Exp Brain Res; 2006 Aug; 173(2):346-52. PubMed ID: 16733694
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.
Gradin KA; Buus CL; Li JY; Frøbert O; Simonsen U
Br J Pharmacol; 2006 Jul; 148(5):703-13. PubMed ID: 16715120
[TBL] [Abstract][Full Text] [Related]
13. Sympathetic and parasympathetic interaction in vascular and secretory control of the nasal mucosa in anaesthetized dogs.
Revington M; Lacroix JS; Potter EK
J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):823-31. PubMed ID: 9457655
[TBL] [Abstract][Full Text] [Related]
14. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
[TBL] [Abstract][Full Text] [Related]
15. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence.
Rimondini R; Thorsell A; Heilig M
Neurosci Lett; 2005 Feb; 375(2):129-33. PubMed ID: 15670655
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
[TBL] [Abstract][Full Text] [Related]
17. Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.
Hyland NP; Sjöberg F; Tough IR; Herzog H; Cox HM
Br J Pharmacol; 2003 Jun; 139(4):863-71. PubMed ID: 12813010
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
Malmström RE
Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
[TBL] [Abstract][Full Text] [Related]
19. Ventricular fibrillation induced by ischemia-reperfusion is not prevented by the NPY Y2 receptor antagonist BIIE0246.
Ilebekk A; Eriksen M; Sevre K; Aspelin T; Björkman JA; Lyberg T; Nordlander M
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):177-83. PubMed ID: 17056830
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological events during neuroeffector transmission in the spleen of guinea-pigs and rats.
Jobling P
J Physiol; 1994 Apr; 476(1):153-65. PubMed ID: 7913966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]